Cargando…
Using 3D-bioprinted models to study pediatric neural crest-derived tumors
The use of three-dimensional (3D) bioprinting has remained at the forefront of tissue engineering and has recently been employed for generating bioprinted solid tumors to be used as cancer models to test therapeutics. In pediatrics, neural crest-derived tumors are the most common type of extracrania...
Autores principales: | Quinn, Colin H, Beierle, Andee M, Julson, Janet R, Erwin, Michael E, Alrefai, Hasan, Markert, Hooper R, Stewart, Jerry E, Hutchins, Sara Claire, Bownes, Laura V, Aye, Jamie M, Mroczek-Musulman, Elizabeth, Hicks, Patricia H, Yoon, Karina J, Willey, Christopher D, Beierle1, Elizabeth A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261178/ https://www.ncbi.nlm.nih.gov/pubmed/37323483 http://dx.doi.org/10.18063/ijb.723 |
Ejemplares similares
-
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
por: Bownes, Laura V., et al.
Publicado: (2022) -
Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor
por: Quinn, Colin H., et al.
Publicado: (2021) -
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
por: Quinn, Colin H., et al.
Publicado: (2022) -
Adrenal extramedullary hematopoiesis in the setting of anti-Diego antibody and congenital dyserythropoietic anemia
por: Julson, Janet Rae, et al.
Publicado: (2022) -
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
por: Bownes, Laura V., et al.
Publicado: (2021)